{
  "_id": "6b95513b8003a681c05cbeaf76e921b29df48219b74a1cff690bc64fa6359540",
  "feed": "market-watch",
  "title": "Merck deal for Seagen unlikely to be finalized ahead of earnings later this month, sources say; Deal talks still on track but upcoming data, arbitration slowed timeline, people familiar with the matter say",
  "text": "<p>The change is due partly to a need to wait for data expected soon from a study evaluating one of Seagen's SGEN treatments, the people said. There is also a desire to possibly see the outcome of a royalties-payments case Seagen is pursuing that is also expected soon, the people said. Both could have an impact on Seagen's valuation.</p><p>An expanded version of this report appears at WSJ.com.</p><p>Top stories on WSJ.com</p><p>Elon Musk Opposes Twitter's Request for Expedited Trial Over Stalled Deal</p><p>Amazon Has Been Slashing Private-Label Selection Amid Weak Sales</p><p>Merck deal for Seagen unlikely to be finalized ahead of earnings later this month, sources say</p>",
  "published": "2022-07-15T22:33:00.000Z",
  "tags": [
    {
      "id": "US58933Y1055",
      "nexusId": "10042334",
      "name": "Merck & Co., Inc.",
      "offsets": [
        {
          "start": 550,
          "end": 555
        },
        {
          "start": 0,
          "end": 5
        }
      ]
    }
  ]
}